Memory CD8+ T cells protect dendritic cells from CTL killing. - Wikidata - wikimedia - TriplyDB

Memory CD8+ T cells protect dendritic cells from CTL killing.

Memory CD8+ T cells protect dendritic cells from CTL killing.

http://www.wikidata.org/entity/Q34000039

about

Therapeutic cancer vaccines and combination immunotherapies involving vaccination Protective memory responses are modulated by priming events prior to challenge.Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells.Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.Programmed cell death of dendritic cells in immune regulation.ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs.Engagement of SLAMF2/CD48 prolongs the time frame of effective T cell activation by supporting mature dendritic cell survival Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.CD40L expression permits CD8+ T cells to execute immunologic helper functions.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells.Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination.Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.Steady-state antigen-expressing dendritic cells terminate CD4+ memory T-cell responses.Good's syndrome, CVID, and selective antibody deficiency in patients with chronic rhinosinusitis.

P2860

Q28397609-B454B116-8618-4ADB-96A5-C3F6BE1BC456 Q30382279-E43B8008-77D8-484E-8D37-FD588A448D2A Q33903742-E1A7D18D-DAA4-4F71-9008-9D19B7A176DD Q34009362-F3FDEE81-AFB4-48DF-A378-81567D2C0030 Q34067493-45D2484E-ABD4-426C-8B3A-8C6FE5BAFB2C Q37448957-4A652A2B-AAC1-41FE-A0E3-4C72032BA93D Q37773421-5F1A2DD1-F4CF-4D7C-8B03-F7A0E41B3E5B Q39023473-5E1864F8-1F75-4F15-8E13-AA7921AC3F36 Q39353271-A9F2C05C-4CCB-467D-8D92-05FF86545CE1 Q39506089-9EC19366-40D9-4FD2-8E26-D9229A449589 Q39666393-CC46AD7B-2B76-4A1B-A8D7-133CEA066861 Q40246112-54CA2E5F-2BA2-4B55-83C3-D6186B39BB4D Q41520681-9F726568-025A-49AE-8266-0A093F2B32AC Q41957729-40398E6B-E1E2-4DD2-A2B9-C61BD6195FB8 Q42238546-193F6512-FE39-4F31-A69F-1249D29426FB Q50535275-321B344D-29A7-466D-845B-1ABF67CF711C Q51057483-2F24A3FA-E106-456C-9957-96427C26F1A5 Q53059952-F5D4D2CF-C1FA-4F45-A406-626A957F77F7

P2860

Memory CD8+ T cells protect dendritic cells from CTL killing.

http://www.wikidata.org/entity/Q34000039

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Memory CD8+ T cells protect dendritic cells from CTL killing.

@ast

Memory CD8+ T cells protect dendritic cells from CTL killing.

@en

Memory CD8+ T cells protect dendritic cells from CTL killing.

@nl

type

label

Memory CD8+ T cells protect dendritic cells from CTL killing.

@ast

Memory CD8+ T cells protect dendritic cells from CTL killing.

@en

Memory CD8+ T cells protect dendritic cells from CTL killing.

@nl

prefLabel

Memory CD8+ T cells protect dendritic cells from CTL killing.

@ast

Memory CD8+ T cells protect dendritic cells from CTL killing.

@en

Memory CD8+ T cells protect dendritic cells from CTL killing.

@nl

P1433

Q34000039-50349638-47EC-4BC9-9949-4700A3488D10

P1476

Q34000039-51A93C4F-E351-4864-AC89-41760F31FABD

P2093

Q34000039-210760BE-CBD2-4BB5-B013-5904675A246C

Q34000039-2170546D-274D-4C4E-B59B-6875E93579BA

Q34000039-73765D26-7AB1-4A32-9759-D3C2E169E363

Q34000039-8ECE2821-E3B1-4BD2-9CA3-F5B05E9F57CC

Q34000039-8F88443E-ACF5-429A-AE9E-CAEAC078222C

Q34000039-A6563274-BD32-428B-B3A2-1A0AFA6E0AB4

Q34000039-C6669112-8253-45E1-8E33-42D8BA50C84D

Q34000039-CCB8AA32-158E-4109-BF6E-0B90575723F8

P2860

Q34000039-0FAF1CEC-B7E2-4B2D-AE87-5F1069CC9467

Q34000039-1402BADC-2C67-4662-BFFD-2496AF8048E2

Q34000039-2756557D-8675-4208-B90B-86876BFBFC46

Q34000039-2CC4CD73-4435-4962-B91F-4B33E57D1649

Q34000039-30575430-0EE2-4354-BC5B-3ECFC36EFA42

Q34000039-37DF51F3-4104-4598-8328-DFCC6B3F65AC

Q34000039-3A8B40C0-D706-443D-99F3-9D3F53AC9D95

Q34000039-3ED57B1E-3964-40F5-B5DA-631FEA51B852

Q34000039-4135B364-3FBD-45AD-8B47-16050E13D8BE

Q34000039-488CCEA8-05B8-4BC4-ACF8-D8767FC6CCED

P304

Q34000039-A82FD7F3-E61D-4DFC-857A-A33262E7FD60

P31

Q34000039-092D5C9E-3BBD-43AD-B74E-32B7CBDE277C

P356

Q34000039-5CB39CF6-E3F8-40D7-814E-3E43FD95BDE7

P407

Q34000039-DCCD50D7-FBB5-4B86-BBA2-E2215B57EEAD

P433

Q34000039-491F4AF8-FAE1-4E60-90DD-35E9A9F3640C

P478

Q34000039-C91518FD-EFCF-4252-91FE-515843D7C05B

P577

Q34000039-5F580950-08B4-422E-9871-D2BA4D74913F

P5875

Q34000039-144098E4-EB5F-4F4A-A267-545135C3D4AC

P698

Q34000039-A0E5748B-D29D-4D19-B8CF-96298F0D87E4

P932

Q34000039-E4C1E133-8675-4F81-997D-07B894854EEF

P356

JIMMUNOL.180.6.3857

P1433

Journal of Immunology

P1476

Memory CD8+ T cells protect dendritic cells from CTL killing.

@en

P2093

Erik Berk

http://www.w3.org/2001/XMLSchema#string

Julie A Urban

http://www.w3.org/2001/XMLSchema#string

Pawel Kalinski

http://www.w3.org/2001/XMLSchema#string

Payal B Watchmaker

http://www.w3.org/2001/XMLSchema#string

Robbie B Mailliard

http://www.w3.org/2001/XMLSchema#string

S Marieke van Ham

http://www.w3.org/2001/XMLSchema#string

Simon C Watkins

http://www.w3.org/2001/XMLSchema#string

Yutaro Nakamura

http://www.w3.org/2001/XMLSchema#string

P2860

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

Adoptive immunotherapy for cancer: building on success

The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites

Lineage relationship and protective immunity of memory CD8 T cell subsets

Interleukin-12 and the regulation of innate resistance and adaptive immunity

A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis

Molecular identification of a danger signal that alerts the immune system to dying cells

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

Natural adjuvants: endogenous activators of dendritic cells.

Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination.

P304

3857-3865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.180.6.3857

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5530553

http://www.w3.org/2001/XMLSchema#string

P698

18322193

http://www.w3.org/2001/XMLSchema#string

P932

2905219

http://www.w3.org/2001/XMLSchema#string